Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 8 | |
Outperform | 15 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 21 analysts offering 12 month price targets for Sarepta Therapeutics Inc have a median target of 200.00, with a high estimate of 219.00 and a low estimate of 147.12. The median estimate represents a 64.46% increase from the last price of 121.61.
High | 80.1% | 219.00 |
Med | 64.5% | 200.00 |
Low | 21.0% | 147.12 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 26, 2025.
Average growth rate | +94.45% |
Average growth rate | +6.55% |
More ▼
Revenue history & estimates in USD
Average growth rate | +10.07% |
Average growth rate | +34.49% |
More ▼